hypericin has been researched along with Ovarian Neoplasms in 6 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nevertheless, both formulations yielded severe photocytotoxicity in SK-OV-3 cells in a therapeutic dosage range." | 1.51 | Photodynamic therapy - hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity. ( Bakowsky, U; Brüßler, J; Duse, L; Goergen, N; Jedelska, J; Pinnapireddy, SR; Plenagl, N; Seitz, BS, 2019) |
| "Moreover, we found that a subset of cancer patients of various cancer-types indeed possessed CALRlow or CRTlow-tumours." | 1.42 | Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal. ( Agostinis, P; de Witte, P; Elsen, S; Garg, AD; Krysko, DV; Vandenabeele, P, 2015) |
| "The high recurrence and lethality of ovarian cancer at advanced stages is problematic, especially due to the development of numerous micrometastases scattered throughout the abdominal cavity." | 1.35 | Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases. ( Delie, F; Gurny, R; Lange, N; Zeisser-Labouèbe, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plenagl, N | 1 |
| Duse, L | 1 |
| Seitz, BS | 1 |
| Goergen, N | 1 |
| Pinnapireddy, SR | 1 |
| Jedelska, J | 1 |
| Brüßler, J | 1 |
| Bakowsky, U | 1 |
| Garg, AD | 1 |
| Elsen, S | 1 |
| Krysko, DV | 1 |
| Vandenabeele, P | 1 |
| de Witte, P | 1 |
| Agostinis, P | 1 |
| Zeisser-Labouèbe, M | 4 |
| Delie, F | 4 |
| Gurny, R | 4 |
| Lange, N | 4 |
| Mattiuzzo, M | 1 |
6 other studies available for hypericin and Ovarian Neoplasms
| Article | Year |
|---|---|
Photodynamic therapy - hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity.
Topics: Angiogenesis Inhibitors; Animals; Anthracenes; Antineoplastic Agents; Cell Line, Tumor; Chickens; Ch | 2019 |
Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Calreticulin; Cancer Vacc | 2015 |
Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases.
Topics: Animals; Anthracenes; Disease Models, Animal; Drug Delivery Systems; Endoscopy; Female; Fluorescence | 2009 |
Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model.
Topics: Animals; Anthracenes; Cell Line, Tumor; Chick Embryo; Chickens; Chorioallantoic Membrane; Early Dete | 2009 |
Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer.
Topics: Anthracenes; Cell Line, Tumor; Drug Delivery Systems; Female; Fluorescence; Humans; Nanoparticles; O | 2009 |
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer.
Topics: Animals; Anthracenes; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Delivery Systems; Female; Hu | 2006 |